ReviewThe Lancet regional health. Europe2026
Oncolytic viruses and neoantigen vaccines: opportunities and challenges in priming antitumour immunity.
André Mansinho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it